MedTrace Logo

Evaluation of Attitudes Towards Organ Donation in Individualistic or Collectivistic Countries

NCT03351881 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2018-02-12

No results posted yet for this study

Summary

People make decisions every day, both for themselves and on behalf of others. In the case of organ donations, despite the opt-out systems used in Singapore where the default is a presumed consent on the part of the individual, the actualized donation rate is lower than expect. This is partially because family members are called in to make surrogate decisions on behalf of the patient, especially patients near brain death or have been certified to be brain dead.

To address the shortfall in organ donations, the investigators plan to run three studies:

* First, the investigators seek to conduct a representative survey of the public's perception towards organ donation. The investigators will focus on their views towards donating their own vs. family members' organs, and to explore the role of cultural influences on decision-making.
* Second, the investigators will conduct the survey focusing on NUS students and the ways they respond to an opt-out, opt-in, or mandatory organ donation system.
* Third, the investigators will conduct the survey on an online platform (MTurk) to gather the views of participants across India and USA about organ donation.

The studies have the potential to improve actualized organ donation rates, as well as to inform the medical community in their communication with family members.

Conditions

  • Opt Out
  • Opt In
  • Opt Neutral

Interventions

OTHER

Description of Organ Donation Policy

Participants will read about an organ donation policy type (opt-out, opt-in, or opt-neutral) and rate what they think or feel about it.

Sponsors & Collaborators

  • Yale-NUS College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-05-31
Completion
2019-05-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03351881 on ClinicalTrials.gov